Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > Potential Outcomes
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by labumbaon Mar 10, 2010 2:14pm
445 Views
Post# 16866718

RE: Potential Outcomes

RE: Potential Outcomesnot agree.....it is a ROLLING review process as for an orphanage status drug.....means drug will get fast approval to be on the market, pershaps, with some warnings but not in the scenario of starting another trial unless the  results from Psoriasis trials are  "cooked "
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities